DEVICES TO MANAGE AORTIC VALVE DISEASE

Tuesday, March 10, 2026

8:00 AM - 10:00 AM EST

Location: International Ballroom West

Moderator(s)

Kendra J. Grubb, MD

VP/CMO Structural Heart
Medtronic
Atlanta, Georgia, United States

Disclosure(s): Medtronic, Inc.: Employee (Ongoing)
Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)

Disclosure(s):

Kendra J. Grubb, MD: Medtronic, Inc.: Employee (Ongoing)

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)